View on Pubmed.gov 41167381 | View on doi.org 10.1016/j.jvs.2...
Guideline-Based Screening for Abdominal Aortic Aneurysms is Significantly Underperformed and Possibly Impacted By Medical Comorbidities.
- Albert Einstein College of Medicine, Bronx, NY. Electronic address: rithva.ramesh@einsteinmed.edu.
- UMass Chan Medical School, Worcester, MA.
- Albert Einstein College of Medicine, Bronx, NY.
- Department of General Surgery, Lahey Hospital and Medical Center, Burlington MA.
- Department of Vascular Surgery, Lahey Hospital and Medical Center, Burlington MA.
- Division of Vascular and Endovascular Surgery, Montefiore Medical Center, Bronx NY.
Abstract
OBJECTIVES
The aim of this study was to define the level of under-screening of abdominal aortic aneurysms (AAAs) and its effect on rupture rates and elucidate if prior medical comorbidities may impact this.
METHODS
The TriNetX Analytics National Database was queried. The United States Preventative Services Task Force (USPSTF) guidelines of male smokers 65 to 75 years and the Society for Vascular Surgery (SVS) guidelines of any smoker 65 years and older were used. Family history for AAA was not used. Three populations were defined: USPSTF-eligible (male smokers 65-75 years old), SVS-eligible (any smoker 65+ years old), and SVS-only-eligible (female smokers 65+ years old, male smokers 75+ years old). For each population, we isolated screened and unscreened individuals. Screened patients were defined as those who underwent a screening ultrasound (US) during the eligible period, and unscreened patients were those who met screening eligibility but did not undergo US as determined by CPT/HCPCS codes. ICD-10 codes were used to identify AAA and comorbidities. Data were matched by propensity score for age, race/ethnicity, and medical utilization (primary care visits, lab orders, etc).
RESULTS
Screening rates for USPSTF-eligible, SVS-eligible, and SVS-only eligible patients were 3.98%, 2.12%, and 0.83%, respectively. Screening according to USPSTF, SVS, and SVS-only guidelines were associated with lower AAA rupture rates (odds ratio [OR], 0.416, 0.499, and 0.717, respectively; P < .05 for each). After propensity matching, a total of 109,444 patients were analyzed with 54,722 patients in each cohort (screened and unscreened). The screened cohort had higher rates of hyperlipidemia (OR, 2.17), hypertension (OR, 1.7), obesity (OR, 1.5), neoplasms (OR, 1.37), inflammatory polyarthropathies (OR, 1.31), systemic connective tissue disorder (OR, 1.25), diabetes mellitus (OR, 1.24), chronic kidney disease (CKD) (OR, 1.2), peripheral vascular disease (PVD) (OR, 1.07), and coronary artery disease (CAD) (OR, 1.06). There were lower rates of paraplegia (OR, 0.43), hemiplegia (OR, 0.7), dementia (OR, 0.76), myocardial infarction (MI) (OR, 0.81), and heart failure (OR, 0.87) in the screened cohort. Each of the above reached statistical significance (P ≤ .01).
CONCLUSIONS
A small percentage of screening-eligible patients were actually screened for AAAs, less so based on SVS guidelines. Screening from each guideline was effective in reducing rupture rates. USPSTF guideline-based screened patients had higher rates of specific medical comorbidities, whereas a prior history of other comorbidities was less prevalent in screened patients. Medical comorbidities may influence clinical decisions to obtain AAA screening.
References
Conflict of interest statement
Conflict of Interest Evan Lipsitz has shares in Access Vascular and is an investigator at Terumo. Neither Access Vascular or Terumo were involved in any aspect of the creation or function of this manuscript. The other authors have no relevant conflict of interest or financial incentives to disclose.
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
Copyright
Copyright © 2025. Published by Elsevier Inc.